Aston University to help power Indonesia with affordable energy made from rice straw

Feb 3, 2023

3 min

Dr Mirjam RöderDr Jude Onwudili
  • Project to convert unwanted rice straw into cheap energy on a commercial scale
  • Most rice straw in Indonesia is burned causing pollution and health problems
  • Project will almost double affordable energy captured from waste.



Scientists at the Energy and Bioproducts Institute at Aston University are to start a project to convert Indonesia’s unwanted rice straw into low-cost energy on a commercial scale.


Each year the country produces 100 million tonnes of the rice waste, of which 60% is burned in open fields, causing air pollution and has even been linked to lung cancer.


The amount burned is equivalent to approximately 85 Terawatts of electricity, which is enough to power Indonesia’s households 10 times over.


A consortium which includes Aston University aims to develop processes to capture more affordable energy from rice straw than ever before - and demonstrate that it can be done on a commercial scale.


Part of the process involves a biomass conversion technology called pyrolysis. This involves heating organic waste materials to high temperatures of around 500 °C to break them down, producing vapour and solid products. Some of the vapour may be condensed into a liquid product called pyrolysis oil or pyrolysis bio-oil. Both the pyrolysis vapour and liquid bio-oil can be converted to electricity.


Current methods convert just 35% of the thermal energy of rice straw to affordable electricity. However, a newly patented combustion engine designed by consortium member, UK-based Carnot Limited, could see that doubled to 70%.


Energy extracted this way could help low and middle-income countries create their own locally generated energy, contribute to net zero by 2050, create new jobs and improve the health of locals.


The project will help develop a business model which could support companies and local authorities to produce local, cheap energy in Indonesia, and other countries with biomass capacity.


Three academic experts from different disciplines at Aston University are involved in this initial project, which focuses on Indonesia’s Lombok Island.


Dr Jude Onwudili, Dr Muhammad Imran and Dr Mirjam Roeder are based at Aston University’s Energy and Bioproducts Research Institute (EBRI).


Dr Jude Onwudili who is leading the team said: “This project has huge potential - commercialisation of this combined technology will have significant economic benefits for the people of Indonesia through direct and indirect job creation, including the feedstock supply chain and electricity distribution and sales.


“About one million Indonesian homes lack access to energy and Indonesia's 6,000 inhabited islands make sustainable infrastructure development challenging in areas such as Lombok Island.


“The new techniques being explored could reduce environmental pollution, contribute to net zero and most importantly, provide access to affordable energy from sustainable local agricultural waste.


“Aston University is a global leader in bioenergy and energy systems, and I am delighted we received funding to explore this area.”


Over a power plant’s life, the project team have calculated that biomass produces cheaper electricity (approx. $4.3$/kWh) compared to solar (approx. $6.6/kWh), geothermal (approx. $6.9/kWh), coal (approx.$7.1/kWh), wind (approx. $8/kWh) and subsidised gas (approx.$8.4ckWh).


The project will start in April 2023 with a total of £1.5 million funding for the four partners from Innovate UK.

Alongside Carnot Limited, the Aston University scientists will be working with two other UK-based businesses to deliver the project, PyroGenesys and Straw Innovations.


PyroGenesys specialises in PyroChemy technology which will convert 70% of the rice straw into vapour or bio-oil for electricity production, with the remainder converted into nutrient-rich biochar, which can be sold back for use as fertiliser on the rice farms.


Straw Innovations will contribute their rice straw harvesting and collection expertise, with their many years of similar operations in Asia.

Connect with:
Dr Mirjam Röder

Dr Mirjam Röder

Associate Professorial Research Fellow, Energy and Bioproducts Research Institute (EBRI)

Dr Röder's research interests focus on bioenergy and related sustainability implications.

SustainabilityNegative EmissionsBioenergy and BioeconomyClimate ChangeBioenergy and Carbon Capture and Storage (BECCS)
Dr Jude Onwudili

Dr Jude Onwudili

Lecturer in Chemical Engineering

Dr Onwudili is an experienced researcher, having worked on a number of projects on catalytic and non-catalytic thermochemic processing.

Advanced Renewable (Bioenergy) TechnologiesRenewable Energy Technologies‎Chemical Product DesignChemical Process DesignAdvanced Process Design

You might also like...

Check out some other posts from Aston University

3 min

Aston University optometrist develops app with the best easy blinking exercises to improve dry eye symptoms

Dry eye disease is a common condition affecting one-third of the adult population and one-in-five children Professor James Wolffsohn researched the most effective blinking exercises to reduce discomfort, involving a close-squeeze-blink cycle He developed the MyDryEye app in collaboration with Alec Kingsnorth and Mark Nattriss to help sufferers An Aston University optometrist, Professor James Wolffsohn, has determined an optimum blinking exercise routine for people suffering with dry eye disease, and has developed a new app, MyDryEye, to help them complete the routine to ease their symptoms. Dry eye disease is a common condition which affects one-third of the adult population and one-in-five children, in which the eyes either do not make enough tears, or produce only poor-quality tears. It causes the eyes to become uncomfortable, with gritty- or itchy-feeling eyes, watery eyes and short-term blurred vision. It is more common in older adults and can be exacerbated by factors including dry air caused by air conditioning, dust, windy conditions, screen use and incomplete blinks, where the eye does not fully close. Professor Wolffsohn is head of Aston University’s School of Optometry and a specialist in dry eye disease. While it has long been known that blinking exercises can ease the symptoms of dry eye disease, the optimum technique, number of repetitions and necessary repeats per day are unclear. Professor Wolffsohn set out to determine the best exercises. His team found that the best technique for a dry eye blinking exercise is a close-squeeze-blink cycle, repeated 15 times, three times per day. Participants found that while they were doing their exercises symptom severity and frequency decreased, and the number of incomplete blinks decreased. Within two weeks of stopping the exercises, their symptoms returned to normal levels, showing the efficacy of the exercises. To carry out the work, Professor Wolffsohn’s team ran two studies. For the first, they recruited 98 participants, who were assessed for dry eye symptoms before and after the two weeks of blinking exercises. Participants were randomly allocated different blinking exercises to determine the most effective. A second study with 28 people measured the efficacy of the blinking exercise. Once the optimum blinking routine had been developed, Professor Wolffsohn worked withAlec Kingsnorth, an engineer and former Aston undergraduate and PhD student, and Mark Nattriss, business manager of his spin-out company, Wolffsohn Research Ltd, to develop the app, MyDryEye, which is freely available on Android and iOS operating systems. The app allows users to monitor their dry eye symptoms, assess their risk factors, add treatment reminders and monitor their compliance, complete the science-based blink exercises and find a specialist near them. Professor Wolffsohn says that the blinking exercises should be carried out as part of a treatment programme which could also include the use of lipid-based artificial tears, omega-3 supplements and warm compresses. Professor Wolffsohn said: “This research confirmed that blink exercises can be a way of overcoming the bad habit of only partially closing our eyes during a blink, that we develop when using digital devices. The research demonstrated that the most effective way to do the exercises is three times a day, 15 repeats of close, squeeze shut and reopen – just three minutes in total out of your busy lifestyle. To make it easier, we have made our MyDryEye app freely available on iOS and Android so you can choose when you want to be reminded to do the exercises and for this to map your progress and how it affects your symptoms.” Read the full paper, ‘Optimisation of Blinking Exercises for Dry Eye Disease’, in Contact Lens and Anterior Eye at https://doi.org/10.1016/j.clae.2025.102453.

2 min

Aston University researchers to take the first steps to find out if AI can help policymakers make urban mobility more sustainable

Researchers to explore how AI can help urban mobility planners They are to investigate AI-driven policy tools’ potential to create greener cities Project to benefit from expertise of five European universities. A European group of researchers led by Aston University is taking the first steps to explore how AI can help urban mobility planners. As city populations grow causing strain on resources, the experts are to investigate AI-driven policy tools’ potential to create greener cities. The team have received £10,000 in funding from the British Academy which they hope will set them on the road to further research. Taking part in the project will be experts from University College London, Ruralis University in Norway, the University of Turin, Italy and Lisbon University Institute, Portugal. Dr Dalila Ribaudo from the Centre for Business Prosperity at Aston Business School and Dr Alina Patelli from the Aston Centre for Artificial Intelligence Research and Application will co-lead a UK-EU consortium consolidation project. The interdisciplinary project will benefit from expertise in applied business and specialist insight into global economics, policymaking and urban transport planning. Dr Patelli said “Policymakers and society could all benefit from our research into innovative ways of managing the strain on urban infrastructures and resources. "The AI-powered policy tools we are developing are meant to support decision managers at all levels of urban governance with reducing emissions, optimising transportation as well as predicting and preventing environmental hazards. Such changes would improve the quality of life for the millions of people living in towns and cities across the UK, Europe and, in the long term, the entire world.” Following the successful bid for the British Academy pump priming grant the team will apply for Horizon Europe funding to continue developing impactful AI-driven policy tools for greener cities.

3 min

New Aston University spin-out company will develop novel ways to treat non-healing wounds

EVolution Therapeutics (EVo) has been founded on the work of Professor Andrew Devitt into the causes of inflammatory disease A failure to control inflammation in the body, usually a natural defence mechanism, can cause chronic inflammation, such as non-healing wounds Non-healing wounds cost the NHS £5.6bn annually, so there is a vital need for new treatments. Aston University’s Professor Andrew Devitt, Dr Ivana Milic and Dr James Gavin have launched a new spin-out company to develop revolutionary treatments to treat chronic inflammation in patients. One of the most common inflammatory conditions is non-healing wounds, such as diabetic foot ulcers, which cost the NHS £5.6bn annually, the same cost as managing obesity. Such wounds are generally just dressed, but clinicians say there is a vital need for active wound treatments, rather than passive management. The spin-out, Evolution Therapeutics (EVo), will aim to create these vital active treatments. Inflammation in the human body helps to fight infection and repair damage following injury and occurs when the immune system floods the area with immune cells. Normally, this inflammation subsides as the damage heals, with the immune system signalling to the immune cells to leave. However, in some cases, the usual healing mechanism is not triggered and the inflammatory response is not turned off, leading to chronic inflammation and so-called inflammatory diseases. EVo is based on Professor Devitt’s work on dying cells in the body, known as apoptotic cells, and how they contribute to health. Dying cells release small, membrane-enclosed fragments called extracellular vesicles (EVs), which alert the immune system to the death of cells, and then trigger the body’s natural repair mechanism and remove the dead cells. It is estimated that 1m cells die every second. Professor Devitt and his team have identified the molecules within the EVs which control the healing process and are engineering new EVs loaded with novel healing enzymes, to drive the body’s repair responses to actively heal wounds. Much of the research has been funded by the Biotechnology and Biological Sciences Research Council (BBSRC) with additional support from the Dunhill Medical Trust. Professor Devitt, Dr Milic and Dr Gavin received Innovation-to-Commercialisation of University Research (ICURe) follow-on funding of £284,000 to develop the vesicle-based therapy with EVo. Most recently, in December 2023, Professor Devitt and Dr Milic were awarded £585,000 from the BBSRC Super Follow-on-Fund to develop engineered cells as a source of membrane vesicles carrying inflammation controlling cargo. The team, together with Professor Paul Topham, also received funding from the National Engineering Biology Programme (£237,000) to support polymer delivery systems for vesicles. EVo is one of the 12 projects being supported by SPARK The Midlands, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, and real-world clinical use. SPARK The Midlands is hosted at Aston University, supported by the West Midlands Health Tech Innovation Accelerator (WMHTIA), and was launched at an event on 31 January 2024. Professor Devitt, EVo chief technical officer, said: “Inflammation is the major driver of almost all disease with a huge contribution to those unwelcome consequences of ageing. We are now at a most exciting time in our science where we can harness all the learning from our research to develop targeted and active therapies for these chronic inflammatory conditions.” Dr Gavin, EVo CEO, said: “The chronic inflammation that results in non-healing wounds are a huge health burden to individuals affecting quality of life as we age but also to the economy. Our approach at EVo is to target the burden of non-healing wounds directly to provide completely novel approaches to wound care treatment. By developing a therapy which actively accelerates wound healing, we hope to drastically improve quality of life for patients, whilst reducing the high cost attached to long term treatment for healthcare systems worldwide.”

View all posts